Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities- FMR LLC
Beam Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Robert Nelsen(6.8%),ARCH Venture Fund IX, L.P.(6.7%), etc.
Beam Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.79%)
Beam Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Joshua J. Dapice(5.0%),Philip D. Dreyfuss(5.0%), etc.
Beam Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(10.985%),Abigail P. Johnson(10.985%)
Beam Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Temasek Holdings (Private) Limited(3.8%)
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ciaramella Giuseppe
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Evans John M.
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Simon Amy
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bellon Christine
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burrell Terry-Ann
Beam Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARK Investment Management LLC(11.53%)
Beam Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.2%)
Beam Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-STATE STREET CORPORATION(5.66%)
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bellon Christine
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner FMR LLC
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Shaw Christi
Beam Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Shaw Christi
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Bellon Christine
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Simon Amy
No Data